Family Care Hospitals Ltd.
Snapshot View

16.70 +0.35 ▲2.1%

27 September 2022, 09:46:00 AM
Volume: 62,711

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.scandent.in
Market Cap 52.48 Cr.
Enterprise Value(EV) 56.86 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.56 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 10.49 Trailing Twelve Months Ending 2022-06
Industry PE 48.77 Trailing Twelve Months Ending 2022-06
Book Value / Share 4.84 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.38 Calculated using Price: 16.35
Dividend Yield 0.61 Period Ending 2022-03
No. of Shares Subscribed 3.21 Cr. 32,100,000 Shares
FaceValue 10
Company Profile
Scandent Imaging is pioneer in providing independent state of the art dental and ENT Imaging solutions. The company provides an exhaustive range of 3D and 2D scan services along with expert reports to cater to the requirements of the dental and ENT fraternity. They specialized and intend to provide complete scanning solutions to the growing demands of the dental and ENT fraternity. Scandent offers the best of technology and scanning experience. The company has designed unique imaging packages that match the requirements of the dental and ENT fraternity as well as the affordability of its end users.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.14%
1 Week
-8.49%
1 Month
-20.67%
3 Month
-63.46%
6 Month
-16.50%
1 Year
-27.39%
2 Year
+92.62%
5 Year
+5.03%
10 Year
+1352.17%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -1,394.79 0.51 3.92 18.96 0.38 0.57 57.85 44.60
Return on Capital Employed (%) -2,238.43 -1,096.64 0.58 4.85 25.41 7.15 7.03 44.54 45.74
Return on Assets (%) -529.42 -1,085.04 0.44 3.13 11.15 0.16 0.18 21.72 17.27

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 0 0 4 4 4 5 5 5 9 14
Non Curr. Liab. 0 0 0 6 7 6 6
Curr. Liab. 0 0 1 1 1 5 3 5 5 20
Minority Int.
Equity & Liab. 0 0 5 5 6 10 14 17 20 40
Non Curr. Assets 2 2 3 9 10 11 9 8
Curr. Assets 0 0 3 3 2 0 3 6 11 32
Misc. Exp. not W/O
Total Assets 0 0 5 5 6 10 14 17 20 40

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 0 0 1 2 5 14 13 35 42 41
Other Income 0 0 0 0 0 0 0 0 0
Total Income 0 0 1 2 5 14 13 35 42 41
Total Expenditure 0 0 -1 -2 -4 -13 -11 -27 -33 -33
PBIDT 0 0 0 0 2 2 2 8 9 9
Interest 0 0 0 -1 -1 -1 -1 0
Depreciation 0 0 0 0 -1 -1 -1 -1 -1
Taxation 0 0 0 0 -2 -2 -2
Exceptional Items -25
PAT 0 -25 0 0 1 0 0 4 5 5
Adjusted EPS -1 -8 0 0 0 0 0 1 2 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 3 -3 0 4 2
Cash Fr. Inv. -2 0 -1 -5 -2 -2 0 0
Cash Fr. Finan. 0 0 5 1 0 5 3 -5 -2
Net Change 0 3 0 0 -2 0 1 -1 0
Cash & Cash Eqvt 0 3 3 2 0 0 2 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 51.24 51.24 51.24 51.24 51.24 51.24 51.24 50.73 42.39
Public 48.76 48.76 48.76 48.76 48.76 48.76 48.76 49.27 57.61
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 16 Sep 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gautam Mohan Deshpande
Tue, 13 Sep 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gautam Deshpande
Thu, 08 Sep 2022
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Gautam Deshpande

Technical Scans View Details >>

Mon, 26 Sep 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 903.35 +0.3%
Divi's Laboratories Ltd. 97,676.51 3,653.90 -0.4%
Cipla Ltd. 85,998.13 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. 51,200.03 1,512.30 0.0%
Max Healthcare Institute Ltd. 40,653.72 411.10 -1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-06 34.59 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 411.10 -1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-06 4.00 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 411.10 -1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 411.10 -1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 411.10 -1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 411.10 -1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 411.10 -1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 411.10 -1.9%

FAQ's On Family Care Hospitals Ltd.

What is Family Care Hospital share price?

Can I buy Family Care Hospital shares now?

What is the Dividend Yield of Family Care Hospital?

What is the Market Cap of Family Care Hospital?

What are the key metrics to analyse Family Care Hospital?

What is the 52 Week High and Low of Family Care Hospital?

What is the trend of Family Care Hospital share price?